Effect of topical herbal cream on Eczema and it’s comparison with Mometasone 0.1%
Phase 2
- Conditions
- Eczema.Atopic dermatitis
- Registration Number
- IRCT20181026041466N5
- Lead Sponsor
- Rayka raya teb co
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
18 years old Men and women or older
One or more eczema lesions
Patients who have not received topical, oral, or injectable medication for the treatment of eczema in the last week
Lack of infection or malignancy at the treatment site (no problem with closed wounds)
Patient's consent to participate in the study
Exclusion Criteria
Under 12 years old
Pregnancy and lactation
Patients with other skin lesions
Patients taking immunosuppressive systemic drugs or biological drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atopic dermatitis disease intensity. Timepoint: At the beginning of the study and about 30 days after starting the topical cream (after treatment). Method of measurement: SCORAD Index form.;Duration of recovery. Timepoint: About 30 days after starting the topical cream (after treatment). Method of measurement: Patient Tracking and Evaluation with SCORAD and DLQI.
- Secondary Outcome Measures
Name Time Method Quality of dermatology patient's life. Timepoint: At the beginning of the study and about 30 days after starting the topical cream (after treatment). Method of measurement: DLQI questionnaire.